Drug Delivery Device With Dose Capturing Module

Patent No. EP2958612 (titled "Drug Delivery Device With Dose Capturing Module") was filed by Novo Nordisk on Feb 19, 2014. The application was issued on Apr 11, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SANOFI AVENTIS DEUTSCHLAND	Jan 11, 2019	VENNER SHIPLEY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Apr 3, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Apr 3, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Mar 31, 2020
Termination of the opposition proceedings with revocation of patent
Jan 2, 2020
(Electronic) Receipt
Jan 2, 2020
Advice of delivery
Jan 2, 2020
Letter accompanying subsequently filed items
Dec 23, 2019
Advice of delivery
Dec 16, 2019
Acknowledgement of a document
Dec 16, 2019
Acknowledgement of a document
Dec 16, 2019
Decision of the Opposition Division and instruction
Dec 16, 2019
Decision revoking the European patent
Dec 16, 2019
Grounds for the decision (Annex) - opposition
Dec 16, 2019
Internal form - Opposition/addressees
Dec 16, 2019
Means of redress
Dec 16, 2019
Scanned annex to a communication - opposition procedure
Feb 11, 2019
Communication of a notice of opposition and request to file observations
Feb 11, 2019
Notice of further oppositions to opponent(s)
Feb 1, 2019
(Electronic) Receipt
Feb 1, 2019
Letter regarding the opposition procedure (no time limit)
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Jan 24, 2019
Request for documents
Jan 17, 2019
Communication of a notice of opposition - first information to patent proprietor
Jan 11, 2019
(Electronic) Receipt
Jan 11, 2019
Notice of opposition
Jan 11, 2019
Notice of opposition
Apr 23, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Mar 15, 2018
Decision to grant a European patent
Jan 22, 2018
Communication regarding the forthcoming grant
Jan 12, 2018
(Electronic) Receipt
Jan 12, 2018
Filing of the translations of the claims
Jan 12, 2018
French translation of claims
Jan 12, 2018
German translation of the claims
Jan 12, 2018
Letter accompanying subsequently filed items
Sep 13, 2017
Bibliographic data of the European patent application
Sep 13, 2017
Communication about intention to grant a European patent
Sep 13, 2017
Intention to grant (signatures)
Sep 13, 2017
Text intended for grant (clean copy)
Sep 13, 2017
Text intended for grant (version for approval)
May 24, 2017
(Electronic) Receipt
May 24, 2017
Amended description with annotations
May 24, 2017
Claims
May 24, 2017
Description
May 24, 2017
Letter accompanying subsequently filed items
May 24, 2017
Reply to communication from the Examining Division
Jan 18, 2017
Annex to the communication
Jan 18, 2017
Communication from the Examining Division
Apr 7, 2016
(Electronic) Receipt
Apr 7, 2016
Amended claims filed after receipt of (European) search report
Apr 7, 2016
Amended description filed after receipt of (European) search report
Apr 7, 2016
Amended description with annotations
Apr 7, 2016
Amendments received before examination
Apr 7, 2016
Letter accompanying subsequently filed items
Dec 2, 2015
Notification on forthcoming publication of bibliographic data
Oct 2, 2015
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Sep 30, 2015
Communication to designated inventor
Sep 30, 2015
Communication to designated inventor
Sep 30, 2015
Communication to designated inventor
Sep 26, 2015
Priority search results copy provided by EPO
Sep 9, 2015
Copy of the international preliminary report on patentability
Aug 25, 2015
(Electronic) Receipt
Aug 25, 2015
Request for entry into the European phase
Jul 3, 2015
Information on entry into European phase
Sep 16, 2014
Priority document (electronically transmitted)
Sep 16, 2014
Priority document (electronically transmitted)
Aug 28, 2014
Copy of the international search report
Aug 28, 2014
Published international application - A1
May 5, 2014
Written opinion of the ISA, boxes No. I to VIII
May 5, 2014
Written opinion of the ISA, cover sheet
May 5, 2014
Written opinion of the ISA, supplemental box
Feb 19, 2014
(Electronic) Receipt
Feb 19, 2014
Abstract
Feb 19, 2014
Claims
Feb 19, 2014
Description
Feb 19, 2014
Drawings
Feb 19, 2014
Priority document (RO-procedure)

EP2958612

NOVO NORDISK

Application Number: EP14705508A
Filing Date: Feb 19, 2014
Status: Revoked; Apr 3, 2020
Publication Date: Apr 11, 2018
External Links: Slate, Register , Google Patents

IP Verse

Drug Delivery Device With Dose Capturing Module

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2958612